Gene Silencing Market Report 2026

Gene Silencing Market Overview

• Gene Silencing market size has reached to $6.69 billion in 2025 • Expected to grow to $12.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.6% • Growth Driver: Rising Prevalence Of Genetic Disorders Fueling The Growth Of The Market Due To Advances In Diagnostic Technologies And Aging Population • Market Trend: Technological Advancements In siRNA Driving Growth In The Market Through Enhanced Precision And Efficacy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Silencing Market?

Gene silencing is a biological process in which the expression of a specific gene is reduced or completely turned off. The process is critical in regulating gene activity, controlling development, and defending against viral infections. Gene silencing is essential in research and medicine, particularly for targeting disease-related genes. The main types of gene silencing include transcriptional, post-transcriptional, and meiotic. Transcriptional refers to anything related to transcription, which is the process by which an RNA molecule is synthesized from a DNA template. The multiple gene silencing involved are RNA interference (RNAi), antisense oligonucleotides (ASOs), clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 -based gene silencing, and others. The various applications include neurology, oncology, infectious diseases, metabolic diseases, therapeutics manufacturing, and others and are used by several end-users such as pharmaceutical and biotechnology companies, research institutes and academic centers, hospitals, clinics, and others.

What Is The Gene Silencing Market Growth Forecast?

The gene silencing market size is expected to see rapid growth in the next few years. It will grow to $12.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to growth of gene therapy pipelines, rising demand for targeted therapeutics, expansion of crispr applications, increased clinical trial activity, development of next-generation gene editing tools. Major trends in the forecast period include growing adoption of rna interference technologies, increasing use of crispr-based gene silencing, expansion of therapeutic gene targeting, rising focus on precision medicine applications, increasing investment in genetic research.

Global Gene Silencing Market Segmentation

1) By Type: Transcriptional, Post-Transcriptional, Meiotic 2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings 3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications 4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users Subsegments: 1) By Transcriptional: DNA Methylation, Histone Modification 2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing 3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

What Is The Driver Of The Gene Silencing Market?

The rising prevalence of genetic disorders is expected to propel the growth of the gene silencing market going forward. Genetic disorders refer to health conditions caused by abnormalities in an individual’s DNA. They are increasingly being identified due to advances in diagnostic technologies, heightened awareness, and broader access to genetic testing. The rising genetic disorders are due to increasing parental age, which elevates the risk of genetic mutations being passed to offspring. Gene silencing offers a promising approach to treating genetic disorders by selectively shutting down the expression of faulty or disease-causing genes. For instance, in August 2023, according to Down Syndrome UK, a UK-based charity, Down syndrome affects an estimated 40,000 people in the UK, with approximately 1 in every 800 babies born with the condition. Therefore, the rising prevalence of genetic disorders is driving the growth of the gene silencing industry.

Key Players In The Global Gene Silencing Market

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Global Gene Silencing Market Trends and Insights

Major companies operating in the gene silencing market are focusing on developing innovative technologies, such as small interfering RNA (siRNA), to enhance precision and efficacy in gene therapy. Small interfering RNA (siRNA) refers to a type of RNA molecule that plays a critical role in the RNA interference (RNAi) pathway by binding to specific messenger RNA (mRNA) and promoting its degradation, preventing the production of disease-causing proteins. For instance, in October 2024, Judo Bio Inc., a US-based biotechnology company, launched siRNA, a next-generation drug using small interfering RNA (siRNA) to silence genes. The unique features include proprietary delivery systems such as lipid nanoparticles or conjugated ligands that ensure efficient uptake by specific cells or tissues and AI-driven platforms that accelerate the identification of viable gene targets.

What Are Latest Mergers And Acquisitions In The Gene Silencing Market?

In September 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, acquired Decibel Therapeutics for an undisclosed amount. Through this acquisition, Regeneron Pharmaceuticals aims to enhance its genetic medicine and gene therapy capabilities, with a particular focus on treating sensory disorders such as genetic hearing loss. Decibel Therapeutics is a US-based company focused on developing gene therapies for hearing loss, including its lead program DB-OTO, which uses a gene silencing approach.

Regional Insights

North America was the largest region in the gene silencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Silencing Market?

The gene silencing market consists of revenues earned by entities by providing services such as services such as gene knockdown assays, RNAi screening services, and epigenetic gene silencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of small interfering RNA, miRNA mimics and inhibitors, reporter assay kits, and therapeutic RNAi-based drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Silencing Market Report 2026?

The gene silencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene silencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.